Chemo Pharma Laboratories Ltd. announced unaudited standalone earnings results for the third quarter and nine months ended December 31, 2017. For the quarter, the company reported revenue from operations of INR 3,225,000 compared with INR 552,000 for the same period a year ago. Profit before exceptional and extra ordinary items and tax was INR 2,095,000 compared with loss of INR 72,000 for the same period a year ago. Profit before tax was 2,095,000 compared with loss of INR 72,000 for the same period a year ago. Net profit for the period was INR 2,095,000 or INR 1.40 per basic and diluted share before and after extraordinary items compared with loss of INR 72,000 or INR 0.05 per basic and diluted share before and after extraordinary items for the same period a year ago. For the nine months, the company reported revenue from operations of INR 6,943,000 compared with INR 2,967,000 for the same period a year ago. Profit before exceptional and extra ordinary items and tax was INR 4,299,000 compared with INR 1,383,000 for the same period a year ago. Profit before tax was INR 4,299,000 compared with INR 1,383,000 for the same period a year ago. Net loss for the period was INR 878,000 or INR 0.59 per basic and diluted share before and after extraordinary items compared with profit of INR 1,383,000 or INR 0.92 per basic and diluted share before and after extraordinary items for the same period a year ago.